Illumina (ILMN) Competitors $94.66 -8.05 (-7.84%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$94.20 -0.45 (-0.48%) As of 08/1/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ILMN vs. A, MTD, WAT, TECH, CRL, BIO, BRKR, PACB, HBIO, and TMOShould you be buying Illumina stock or one of its competitors? The main competitors of Illumina include Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Bio-Techne (TECH), Charles River Laboratories International (CRL), Bio-Rad Laboratories (BIO), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), and Thermo Fisher Scientific (TMO). These companies are all part of the "life sciences tools & services" industry. Illumina vs. Its Competitors Agilent Technologies Mettler-Toledo International Waters Bio-Techne Charles River Laboratories International Bio-Rad Laboratories Bruker Pacific Biosciences of California Harvard Bioscience Thermo Fisher Scientific Agilent Technologies (NYSE:A) and Illumina (NASDAQ:ILMN) are both large-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, media sentiment, risk, profitability, valuation and earnings. Does the media prefer A or ILMN? In the previous week, Illumina had 23 more articles in the media than Agilent Technologies. MarketBeat recorded 47 mentions for Illumina and 24 mentions for Agilent Technologies. Agilent Technologies' average media sentiment score of 1.04 beat Illumina's score of 0.99 indicating that Agilent Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agilent Technologies 16 Very Positive mention(s) 4 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Illumina 20 Very Positive mention(s) 9 Positive mention(s) 12 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, A or ILMN? Agilent Technologies has a beta of 1.22, meaning that its stock price is 22% more volatile than the S&P 500. Comparatively, Illumina has a beta of 1.37, meaning that its stock price is 37% more volatile than the S&P 500. Which has higher earnings & valuation, A or ILMN? Agilent Technologies has higher revenue and earnings than Illumina. Illumina is trading at a lower price-to-earnings ratio than Agilent Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAgilent Technologies$6.51B4.95$1.29B$4.0528.03Illumina$4.37B3.43-$1.22B-$6.07-15.59 Is A or ILMN more profitable? Illumina has a net margin of 29.36% compared to Agilent Technologies' net margin of 17.59%. Illumina's return on equity of 28.84% beat Agilent Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Agilent Technologies17.59% 25.92% 13.24% Illumina 29.36%28.84%10.70% Do institutionals & insiders have more ownership in A or ILMN? 89.4% of Illumina shares are owned by institutional investors. 2.6% of Illumina shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Do analysts prefer A or ILMN? Agilent Technologies presently has a consensus target price of $139.77, suggesting a potential upside of 23.13%. Illumina has a consensus target price of $127.21, suggesting a potential upside of 34.39%. Given Illumina's higher possible upside, analysts clearly believe Illumina is more favorable than Agilent Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Agilent Technologies 0 Sell rating(s) 6 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.54Illumina 2 Sell rating(s) 9 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.40 SummaryIllumina beats Agilent Technologies on 9 of the 17 factors compared between the two stocks. Get Illumina News Delivered to You Automatically Sign up to receive the latest news and ratings for ILMN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ILMN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ILMN vs. The Competition Export to ExcelMetricIlluminaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$14.98B$3.02B$5.53B$9.37BDividend YieldN/A2.44%4.74%4.12%P/E Ratio11.9817.6228.8823.79Price / Sales3.43309.96440.8796.30Price / Cash20.1841.6335.0757.18Price / Book6.338.488.255.54Net Income-$1.22B-$55.06M$3.25B$259.88M7 Day Performance-13.39%-3.99%-3.75%-4.67%1 Month Performance-5.66%9.58%4.26%4.40%1 Year Performance-19.58%6.70%25.83%17.91% Illumina Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ILMNIllumina4.9322 of 5 stars$94.66-7.8%$127.21+34.4%-22.6%$14.98B$4.37B11.989,030Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionGap DownHigh Trading VolumeAAgilent Technologies4.7655 of 5 stars$119.54-0.5%$139.77+16.9%-20.5%$33.96B$6.51B29.5217,900News CoveragePositive NewsMTDMettler-Toledo International3.8372 of 5 stars$1,259.15-0.4%$1,298.50+3.1%-20.9%$26.17B$3.87B31.4017,300Trending NewsEarnings ReportWATWaters4.7361 of 5 stars$302.51-0.1%$381.94+26.3%-17.5%$18.00B$2.96B27.457,600Trending NewsUpcoming EarningsShort Interest ↑TECHBio-Techne4.8621 of 5 stars$58.55-0.4%$69.58+18.8%-33.3%$9.18B$1.21B71.403,100News CoveragePositive NewsUpcoming EarningsCRLCharles River Laboratories International4.3054 of 5 stars$179.10+1.2%$174.54-2.5%-31.3%$8.80B$4.05B-275.5420,100Positive NewsUpcoming EarningsBIOBio-Rad Laboratories4.652 of 5 stars$253.24-4.1%$324.25+28.0%-16.6%$6.89B$2.57B-3.327,700Trending NewsEarnings ReportAnalyst ForecastGap UpBRKRBruker4.955 of 5 stars$43.93+4.7%$52.89+20.4%-44.4%$6.66B$3.45B84.4811,396Upcoming EarningsPACBPacific Biosciences of California2.5048 of 5 stars$1.64+6.5%$2.06+25.7%-30.7%$492.13M$154.01M-0.59730Upcoming EarningsHBIOHarvard Bioscience4.2337 of 5 stars$0.53-6.3%$3.00+466.9%-85.8%$23.40M$94.14M-0.40490TMOThermo Fisher Scientific4.9926 of 5 stars$484.90+1.4%$593.00+22.3%-25.6%$183.04B$42.88B28.05125,000Positive NewsAnalyst Upgrade Related Companies and Tools Related Companies Agilent Technologies Alternatives Mettler-Toledo International Alternatives Waters Alternatives Bio-Techne Alternatives Charles River Laboratories International Alternatives Bio-Rad Laboratories Alternatives Bruker Alternatives Pacific Biosciences of California Alternatives Harvard Bioscience Alternatives Thermo Fisher Scientific Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ILMN) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredOne stock to replace NvidiaInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Illumina, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Illumina With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
